Get the latest Science News and Discoveries

Investigational KRAS(ON) inhibitor zoldonrasib showed effective and durable responses in patients with advanced G12D-mutated lung cancer - EurekAlert!

Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.

None

Related news:

Next-generation KRAS G12C inhibitor elisrasib elicited promising response rates in patients with advanced lung cancer - EurekAlert!

AACR: New platform uses machine learning to predict responses in patients with lung cancer - EurekAlert!

Believing in a "chemical imbalance" might keep patients on antidepressants longer